Sales Nexus CRM

Scottsdale TMS Therapy Expands Insurance Coverage to Include Cigna, Aetna, and UMR for Advanced Depression Treatments

By FisherVista
Scottsdale TMS Therapy has confirmed integration of Cigna, Aetna, and UMR into its coverage verification, reducing financial barriers for patients seeking TMS and Spravato treatments for treatment-resistant depression, anxiety, and OCD.
Scottsdale TMS Therapy Expands Insurance Coverage to Include Cigna, Aetna, and UMR for Advanced Depression Treatments

Scottsdale TMS Therapy has announced the integration of major national insurance plans—including Cigna, Aetna, and UMR—into its coverage verification framework, a move that aims to reduce financial uncertainty for individuals managing treatment-resistant depression, anxiety, and obsessive-compulsive disorder (OCD). The confirmed insurance relationships are designed to connect patients with advanced clinical options while lowering out-of-pocket costs, addressing a key barrier that often delays treatment decisions.

For patients exploring options beyond standard pharmaceuticals, the newly verified benefits extend to advanced interventional therapies and broader psychiatric care. Depending on an individual's specific policy design, coverage may include Transcranial Magnetic Stimulation (TMS), Spravato (esketamine) nasal spray, and psychiatric medication management. This expansion is expected to benefit adults and young adults throughout the Scottsdale region who have struggled to afford these treatments.

“For individuals managing treatment-resistant depression or severe anxiety, finding a treatment that works is only half the battle—the other half is figuring out how to afford it,” said a spokesperson for Scottsdale TMS Therapy. “By confirming our framework with major insurance networks like Cigna, Aetna, and UMR, we are removing financial ambiguity from the equation. This ensures that adults and young adults across Scottsdale can access our advanced interventional modalities, like TMS and Spravato, alongside their broader psychiatric care with a clear, predictable path forward.”

The confirmed insurance coverage applies directly to the clinic’s specialized treatment offerings. TMS is an FDA-cleared, non-invasive treatment that uses pulsed magnetic fields to stimulate brain regions involved in mood regulation, typically requiring 30 to 36 sessions over four to six weeks. Spravato, an FDA-approved nasal spray, targets a distinct pathway in the brain to support neural connections, often providing relief within days, and is administered under medical supervision in accordance with REMS safety requirements. Additionally, psychiatric medication management involves thorough evaluations and individualized treatment planning by board-certified psychiatrists and nurse practitioners.

Scottsdale TMS Therapy maintains an in-house team including licensed psychiatrists, primary mental health nurse practitioners, licensed therapists, and certified TMS technicians, allowing for a cohesive, multi-disciplinary approach. Patients can also incorporate psychotherapy into their recovery plans with master’s-level licensed counselors. The clinic’s environment is designed with calming aesthetics, relaxing music, and restorative decor to help patients feel at ease.

For more information or to complete a confidential insurance coverage verification, visit scottsdaletmstherapy.com.

FisherVista

FisherVista

@fishervista